• Interaction Score: 0.63

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    combination therapy Reolysin + Gemcitabine
    Indication/Tumor Type pancreatic cancer
    Response Type sensitive

  • Interaction Score: 0.63

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Reolysin
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 0.44

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Novel Target
    Trial Name Reolysin

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial